Double maintains 2 strategies that include RCKT - Rocket Pharmaceuticals, Inc.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ALHC | -0.01% | $2.69B | +71.20% | 0.00% |
| ZYXI | -0.03% | $81.34M | -69.84% | 0.00% |
| AJG | 0.06% | $80.86B | +20.22% | 0.79% |
| FE | -0.07% | $22.95B | +3.43% | 4.32% |
| WELL | -0.07% | $98.56B | +43.06% | 1.78% |
| ENSG | -0.08% | $8.56B | +17.80% | 0.16% |
| SPTN | 0.09% | $898.36M | +47.04% | 3.30% |
| LW | -0.10% | $7.45B | -36.19% | 2.76% |
| BTU | -0.11% | $1.79B | -37.24% | 2.04% |
| ARCO | -0.13% | $1.64B | -14.10% | 3.08% |
| FUBO | -0.14% | $1.25B | +178.63% | 0.00% |
| VIV | -0.15% | $18.81B | +44.82% | 0.66% |
| ZBH | 0.16% | $18.50B | -12.27% | 1.02% |
| TME | -0.18% | $13.41B | +28.31% | 0.94% |
| BTI | 0.18% | $103.67B | +50.78% | 6.33% |
| SBS | 0.18% | $14.57B | +48.61% | 3.04% |
| OSCR | 0.19% | $4.23B | -2.64% | 0.00% |
| MCS | -0.20% | $523.24M | +53.09% | 1.64% |
| T | 0.21% | $203.71B | +51.55% | 3.92% |
| CAG | 0.26% | $10.09B | -24.85% | 6.62% |
Current Value
$2.911 Year Return
Current Value
$2.911 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RGNX | 48.40% | $434.35M | -20.33% | 0.00% |
| DNLI | 47.09% | $2.16B | -30.05% | 0.00% |
| RVMD | 46.79% | $6.93B | +0.73% | 0.00% |
| PRTA | 45.83% | $340.19M | -68.51% | 0.00% |
| ACLX | 44.89% | $3.66B | +21.24% | 0.00% |
| KYMR | 44.27% | $3.12B | +47.65% | 0.00% |
| SKY | 43.84% | $3.87B | +0.90% | 0.00% |
| OCUL | 43.25% | $1.51B | +41.41% | 0.00% |
| BEAM | 43.19% | $2.00B | -15.33% | 0.00% |
| STOK | 42.47% | $630.59M | -8.84% | 0.00% |
| XNCR | 42.20% | $590.72M | -55.40% | 0.00% |
| SYRE | 42.09% | $935.48M | -39.83% | 0.00% |
| RYTM | 41.80% | $4.26B | +63.98% | 0.00% |
| IMVT | 41.59% | $2.87B | -35.84% | 0.00% |
| NTLA | 41.50% | $1.11B | -53.25% | 0.00% |
| RNA | 41.05% | $3.54B | -21.10% | 0.00% |
| CGON | 41.03% | $2.03B | -13.46% | 0.00% |
| REPL | 40.97% | $736.18M | +18.05% | 0.00% |
| RARE | 40.85% | $3.73B | -1.87% | 0.00% |
| XENE | 40.56% | $2.56B | -7.61% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 51.86% | $4.82B | 0.35% |
| GNOM | 50.14% | $44.57M | 0.5% |
| IBB | 45.27% | $5.26B | 0.45% |
| ARKG | 39.79% | $1.02B | 0.75% |
| XPH | 37.45% | $147.96M | 0.35% |
| PBE | 37.29% | $223.19M | 0.58% |
| BBH | 37.13% | $330.62M | 0.35% |
| IWC | 36.08% | $818.14M | 0.6% |
| PTH | 35.53% | $100.85M | 0.6% |
| FBT | 34.83% | $1.01B | 0.54% |
| KJUL | 33.05% | $119.50M | 0.79% |
| KSA | 32.89% | $696.96M | 0.75% |
| IWMY | 32.61% | $119.32M | 1.02% |
| IWO | 32.60% | $11.60B | 0.24% |
| IWM | 32.11% | $63.72B | 0.19% |
| VTWO | 31.93% | $12.52B | 0.07% |
| KJAN | 31.30% | $287.30M | 0.79% |
| SCHA | 30.87% | $17.26B | 0.04% |
| QQQJ | 30.70% | $621.52M | 0.15% |
| IWN | 30.65% | $10.96B | 0.24% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HOLX | -22.24% | $14.55B | -11.13% | 0.00% |
| CIG.C | -19.71% | $2.65B | +29.61% | 0.00% |
| IMNN | -18.07% | $16.26M | -34.16% | 0.00% |
| AMC | -16.97% | $1.25B | -42.74% | 0.00% |
| IRBT | -15.70% | $99.85M | -63.89% | 0.00% |
| CNC | -13.95% | $16.81B | -49.40% | 0.00% |
| GNE | -9.83% | $661.74M | +62.38% | 1.21% |
| EXC | -9.83% | $43.33B | +23.58% | 3.62% |
| PSQH | -9.55% | $98.82M | -36.55% | 0.00% |
| CHD | -9.53% | $24.14B | -7.11% | 1.19% |
| MOH | -8.83% | $12.95B | -19.36% | 0.00% |
| HUSA | -7.39% | $19.66M | -19.53% | 0.00% |
| COR | -7.37% | $56.44B | +30.86% | 0.74% |
| ACI | -7.36% | $12.40B | +10.61% | 2.47% |
| ED | -7.02% | $36.00B | +12.64% | 3.34% |
| K | -6.92% | $27.76B | +41.17% | 2.85% |
| LITB | -6.82% | $21.24M | -78.57% | 0.00% |
| CBOE | -6.30% | $24.23B | +35.36% | 1.09% |
| UTZ | -6.11% | $1.14B | -19.23% | 1.82% |
| AQB | -5.92% | $2.96M | -53.35% | 0.00% |
Finnhub
LOS ANGELES, July 3, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Rocket Pharmaceuticals, Inc. have opportunity to lead the securities fraud...
Finnhub
NEW YORK, July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ...
Finnhub
Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their OptionsIf you purchased...
Finnhub
Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who...
Finnhub
NEW YORK, July 2, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor...
Finnhub
NEW YORK, July 2, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. . Such investors are advised to contact Danielle...
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| CGCP | 0.05% | $5.17B | 0.34% |
| IBDV | 0.06% | $1.91B | 0.1% |
| IBDY | 0.08% | $760.46M | 0.1% |
| BILZ | -0.10% | $821.74M | 0.14% |
| MEAR | 0.11% | $1.13B | 0.25% |
| IGOV | -0.11% | $1.22B | 0.35% |
| BSCV | -0.12% | $1.06B | 0.1% |
| PHDG | -0.17% | $90.24M | 0.39% |
| IBDX | 0.18% | $1.12B | 0.1% |
| IBMP | 0.19% | $553.65M | 0.18% |
| BSCT | -0.26% | $2.11B | 0.1% |
| SCHI | 0.29% | $8.71B | 0.03% |
| SPLB | 0.31% | $1.20B | 0.04% |
| BSCP | 0.43% | $3.28B | 0.1% |
| PWZ | -0.48% | $759.91M | 0.28% |
| MMIN | -0.52% | $336.10M | 0.3% |
| SPSK | -0.53% | $321.02M | 0.5% |
| JSI | 0.61% | $874.13M | 0.49% |
| IBDR | 0.64% | $3.34B | 0.1% |
| GRNB | -0.65% | $132.98M | 0.2% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -26.14% | $99.63M | 0.59% |
| BTAL | -25.76% | $296.22M | 1.43% |
| VIXY | -22.75% | $164.54M | 0.85% |
| SHAG | -19.85% | $43.05M | 0.12% |
| IVOL | -16.60% | $347.03M | 1.02% |
| SHYM | -15.15% | $357.13M | 0.35% |
| FLGV | -14.72% | $1.03B | 0.09% |
| AGZ | -12.80% | $614.58M | 0.2% |
| VGIT | -12.18% | $31.89B | 0.04% |
| LGOV | -12.07% | $678.86M | 0.67% |
| IEI | -11.95% | $15.48B | 0.15% |
| GOVZ | -11.68% | $272.00M | 0.1% |
| UTEN | -11.58% | $210.24M | 0.15% |
| IBTM | -11.29% | $316.49M | 0.07% |
| SCHO | -11.17% | $11.03B | 0.03% |
| GOVI | -11.13% | $929.28M | 0.15% |
| IBTL | -11.07% | $381.01M | 0.07% |
| SCHR | -11.04% | $10.92B | 0.03% |
| IBTO | -11.00% | $352.69M | 0.07% |
| XONE | -10.90% | $625.28M | 0.03% |
